Thursday, September 29th, 18h00-18h30
Room C
Sartorius Stedim Biotech presents the first fully
integrated upstream platform which helps biopharmaceutical companies to reach
the clinic faster. Sartorius Stedim Cellca has developed and optimized an
efficient platform, which consists of 4 key components: high producer CHO cell
line, expression vector, chemically defined media system and an easy, scalable
and sustainable cultivation process. In 95% of projects the Cellca CHO
Expression Platform can deliver a minimum titer of 3 g/L in a reduced developed
timescale.
Sonia MECONI: Analytical Services Business Development Manager, SARTORIUS STEDIM BIOTECH (France)